Rating: Cautious Sell | Target Price: 18–30 yuan | Current Price: 49 yuan (Close 2026-07-27) | Margin of Safety: -63% (Lower End of Base-Case Fair Value) | Time Horizon: 12–18 Months
ChangXin Memory Technologies is the only IDM enterprise in mainland China capable of mass-producing DRAM, with a scarce franchise—its domestic substitution narrative and market share growth trend are genuine and strong amid the global AI-driven memory super cycle. However, the first-day closing price of 49 yuan implies a market cap of 3.28 trillion yuan, far exceeding our base-case fair value of 18–30 yuan per share. Current DRAM contract prices are at historical 90%+ percentile; the Q3 2026 price increase has sharply converged from 90–95% in Q1 to 13–18%, raising the risk of a cycle peak. Quality is good but valuation is extremely expensive. Recommend avoiding and reassessing entry timing after the cycle corrects.
Key Evidence:
ChangXin’s revenue and profit are almost entirely dependent on the DRAM price cycle—Q1 2026 shipment volume grew only 11%, while ASP surged 57%, the main driver of profit explosion. Current DRAM contract prices are at historical 90%+ percentile; Q3 2026 price increases have notably narrowed from 90–95% in Q1 to 13–18%, with weakening consumer electronics demand (smartphone/PC shipments both declining) eroding pricing momentum. Historical experience shows a 2–4 quarter lag between quarterly DRAM price increase convergence and final peaking (e.g., after Q2 2017 convergence, prices continued rising for 4 quarters before peaking), and this cycle’s AI structural demand (HBM capacity crowding out general DRAM) may prolong the cycle—but "inability to sustain increases" is itself a signal. Cycle peaking is a high-probability direction, with a time window of 2027H2–2028H1.
Key Evidence:
ChangXin’s domestic substitution narrative is genuine and strong—ByteDance and Tencent combined long-term agreements exceeding 67 billion yuan lock in demand for several years, with capacity already booked through end-2027. However, note: long-term contract terms (minimum purchase quantities, pricing mechanisms, default penalties) are not fully disclosed; customers may choose to default or renegotiate in the event of a sharp DRAM price decline. Technology gap and cost disadvantage are masked by high gross margins (79.16% in Q1 2026) during the super cycle; once prices decline, cost disadvantage will be sharply magnified—ChangXin’s current high gross margin is a cyclical benefit, not a structural competitive advantage.
Key Evidence:
Divergent market views exist: Northeast Securities (2026-07-27) gave a valuation range of 3.2–5.7 trillion yuan (~48–85 yuan/share), Nomura target price 116 yuan—their valuation framework heavily relies on domestic substitution premium and sustained high DRAM prices. Our base case adopts more conservative assumptions: gradual normalization of DRAM prices, capacity ramp as planned, 20–25x mid-cycle PE (anchoring to SK Hynix historical mid-cycle PE center of ~25x), yielding fair value of 18–30 yuan. Even incorporating domestic substitution premium, the current price of 49 yuan has already priced in most of the upside under the most optimistic scenario, with odds skewed to the downside—upside to bull-case center (55 yuan) is only +12%, while downside to base-case center (24 yuan) is -51%.
Key Evidence:
HBM is the most lucrative profit segment in AI memory, and ChangXin is almost absent from it. Market opposition argues that Nomura’s 20x PE target price already implies a valuation premium far exceeding the Big Three—but this premium comes from the domestic substitution + market share growth narrative, not HBM competitiveness. Without access to the high-end HBM market, ChangXin will always be a "general DRAM cyclical stock," with a valuation ceiling far lower than that of the Korean duo that have HBM pricing power. Need to continuously track the Shanghai packaging plant’s end-2026 production start and HBM3 customer qualification progress.
Key Evidence:
Market opposition correctly points out: the probability of Entity List implementation is ~35% (this report’s risk assessment), and the U.S. has not updated the Entity List since October 2025—there is political divergence and room for negotiation. Apple’s active lobbying and overseas OEM certification progress indicate that demand has not retreated due to sanctions risk. Furthermore, ChangXin has achieved 31% domestic equipment sourcing, targeting over 50% by 2027, enhancing enterprise-level hedging capability. However, if the Entity List is implemented (even if low probability), the consequences are devastating: equipment supply cutoff → process stagnation → loss of overseas customers → ceiling on global market share. The severity of the tail risk warrants continuous vigilance.
| Metric | 2023 | 2024 | 2025 | Q1 2026 |
|---|---|---|---|---|
| Revenue (billion yuan) | ~21.0 | ~35.0 | ~61.8 | 50.8 |
| Net profit attributable to parent (billion yuan) | -16.3 | ~0.5 | ~1.9 | 24.762 |
| Recurring/non-recurring net profit (billion yuan) | — | — | ~-1.5 | — |
| Gross margin | — | — | ~38-41% | 79.16% |
| Net margin | — | — | ~3% | 48.7% |
| Operating cash flow (billion yuan) | — | — | — | — |
| Free cash flow (billion yuan) | — | — | — | — |
| Cash + cash equivalents (billion yuan) | — | — | — | — |
| Interest-bearing debt (billion yuan) | — | — | — | — |
| Debt-to-asset ratio | — | — | ~51% | — |
| Depreciation (billion yuan) | 10.555 | 14.875 | 24.680 | — |
Data Note: The company listed on 2026-07-27; cninfo has not yet included historical filings. The above data is compiled from the prospectus (registration version) and news reports. Revenue for 2023–2024 is industry estimates; 2025 revenue of approximately 61.8 billion yuan is based on cross-validation from SemiAnalysis/Reuters etc. “—” indicates not available.
Reason for metric changes (≥±20% change):
ChangXin Memory Technologies reported Q1 2026 revenue of 50.8 billion yuan (+719% YoY), net profit attributable to parent of 24.762 billion yuan (+1688% YoY), quarterly gross margin surging to 79.16%, net margin 48.7%—this profitability level surpasses Samsung DS and SK Hynix, and is almost entirely driven by DRAM price increases (shipment volume grew only ~11%, ASP rose ~57%).
Management’s 2026H1 earnings guidance: Revenue 110–120 billion yuan (+612–677% YoY), net profit attributable to parent 50–57 billion yuan (+2244–2544% YoY). Based on mid-point estimates, H1 revenue ~115 billion yuan, net profit ~53.5 billion yuan, annualized ~107 billion yuan—consistent with our FY2026E forecast (100–130 billion yuan).
Key Focus: Implied Q2 revenue of ~59.2–69.2 billion yuan, net profit ~25.2–32.2 billion yuan, up slightly from Q1—but Q3 contract price increases have already narrowed to 13–18% (vs Q1’s 90–95%), and profit growth in subsequent quarters will clearly slow or even turn negative. If H2 prices are flat or slightly down, under the drag of rigid depreciation (annualized 25+ billion yuan), profit margins will contract rapidly.
Sell-side consensus for FY2026E net profit attributable to parent is ~144.5 billion yuan (n=3), implying H2 ~91 billion yuan—requiring H2 prices to remain high and shipment volume to continue rising. Given the Q3 price increase convergence signal already appearing, we believe this consensus is too optimistic.
ChangXin Memory Technologies adopts an IDM (Integrated Device Manufacturer) model, covering the full chain of DRAM design → wafer fabrication → packaging & testing. It is the only company in mainland China achieving mass production of DRAM. Business model characteristics:
The company just listed; historical cash flow data is incomplete, preventing multi-year calculation of OCF/net profit and FCF/net profit. However, qualitative judgments can be made:
ROIC estimates are distorted by historical losses and current profit explosion: heavy losses in 2023, marginal profit in 2025, massive profit in 2026—any single-year ROIC is not representative. Using annualized net profit for 2026H1 of ~107 billion yuan and invested capital of ~300–350 billion yuan (total assets 388.2 billion yuan minus non-interest-bearing liabilities), a rough calculation yields ROIC of ~30–35%, extremely high but unsustainable. From a mid-cycle perspective (after DRAM price normalization), ROIC may drop to 8–15%, roughly matching or slightly exceeding the industry WACC (~10–12%), not constituting significant excess returns.
CapEx / Depreciation far exceeds 1.5: The company is in a "super CapEx cycle" of expanding three fabs simultaneously—2025 depreciation was 24.68 billion yuan, while equipment procurement (IPO-funded portion alone) was 22.0 billion yuan, and total investment in the new Shanghai fab is hundreds of billions of yuan. This ratio is typical of a "capital black hole" during expansion phase: annual earnings are far from sufficient to fund reinvestment, and shareholders essentially receive no free cash flow—this is normal in semiconductor manufacturing, not exceptional, but investors must recognize that ChangXin is not a free-cash-flow-generating business over the next 3–5 years, but a growth stock continuously consuming capital.
Given that the company just listed, historical public commitments and track record are limited; preliminary judgment based on the prospectus and roadshow information:
ChangXin’s main business is highly concentrated in DRAM chips; the company does not disclose segment data by product line. A rough breakdown by application scenario:
| Application Segment | Estimated Revenue Share | Product | Business Logic |
|---|---|---|---|
| Server DRAM | ~30–35% | DDR5 RDIMM | AI server demand explosion, benefiting from ByteDance/Tencent long-term agreements |
| Mobile DRAM | ~25–30% | LPDDR4X/5/5X | Smartphone memory upgrade, domestic substitution for OPPO/vivo/Xiaomi |
| PC/Consumer DRAM | ~20–25% | DDR4/DDR5 UDIMM | Collaboration with Lenovo/Dell/HP progressing; consumer electronics weakening |
| Other (incl. HBM) | ~5–10% | HBM2/GDDR | HBM just started, almost no material revenue in 2026 |
Main profit segment: In the super cycle, server DRAM, due to the highest ASP and high DDR5 mix, is the core profit contributor. However, since the company does not disclose segment gross margins, precise profit contribution cannot be calculated.
Gross margin structure differences: DDR5 (server) gross margin is higher than DDR4 (consumer); HBM gross margin is theoretically 3x+ that of general DRAM but ChangXin has not yet generated scale revenue. The company’s overall gross margin (79.16% in Q1 2026) is at a leading level in the industry’s cyclical high, but the gross margin gap between product lines will widen during a cyclical downturn.
The company has a single main business and does not disclose segments. The above is an estimated breakdown based on product application areas, not the company’s official disclosure.
Based on the financial information disclosed in the prospectus (Registration Draft, updated 2026-05-17):
| Red Flag | Severity | Evidence from Prospectus |
|---|---|---|
| Depreciation policy – rigidity of depreciation during capacity ramp-up erodes profits | Medium | Risk Factors: "Depreciation was RMB 10.555 billion, RMB 14.875 billion, and RMB 24.680 billion in 2023, 2024, and 2025 respectively, and will continue to increase going forward" |
| Accumulated deficit of RMB 36.65 billion – historically covered by government grants and financing | Medium | "As of December 31, 2025, the company's accumulated deficit was RMB 36.650 billion" |
| 2025 recurring net profit (excl. non-recurring items) attributable to parent was negative (approx. -RMB 1.5 billion), while net profit attributable to parent was barely positive (approx. RMB 1.875 billion) – non-recurring items dressed up parent-level profitability | Medium | Offering PE (2025 recurring) 308x vs. Static PE 1,748x – the huge gap reflects the profit divide between recurring and reported figures |
| Accounts receivable and inventory – inventory gains during DRAM price upcycle but faces impairment risk when cycle reverses | Low | Work-in-progress balance is high, inventory turnover needs attention |
The company's disclosed period covers only 2023–2025 plus 2026Q1 (prospectus + performance guidance), less than three full fiscal years. Inter-period consistency cannot be assessed at this stage.
Based on the available prospectus and public information, the company exhibits noteworthy financial characteristics such as a cyclical peak IPO and a large gap between recurring and reported profits, but due to the short disclosure history, inter-period consistency cannot be evaluated. No clear evidence of accounting fraud or aggressive revenue recognition was found.
| Metric | Value | Note |
|---|---|---|
| Share Price | RMB 49 | Close as of 2026-07-27 |
| Total Shares | 66.881 billion | Before exercise of over-allotment option |
| Market Cap | ~RMB 3.28 trillion | Largest by A-share market cap |
| PE (TTM) | 116x | At cyclical peak, not representative |
| PB | 40.1x | Far above peers (Samsung 3.5x / SK Hynix 10.9x / Micron 16.7x) |
| PS (TTM) | 30.8x | Close to Micron 26.7x |
| Forward PE (FY2027E) | 13x | Based on sell-side consensus EPS of RMB 3.77 |
PE Percentile Note: No historical percentile data since listing day. PE(TTM) of 116x is at an extreme high, but current earnings are at the peak of the AI super-cycle – in DRAM cyclical stocks, a low PE at peak earnings is a classic "valuation trap" signal. The percentile is for reference only and does not constitute a valuation judgment.
What does the market believe at a price of RMB 49? If we assign a mid-cycle PE of 20–25x (anchored to SK Hynix's historical mid-cycle PE median of ~25x), the current price implies CXMT needs to generate net profit attributable to parent of approximately RMB 131.0–164.0 billion per year. Sell-side consensus for FY2027E net profit attributable to parent is approximately RMB 252.2 billion (EPS RMB 3.77 x 66.881 billion shares), far exceeding this level – meaning the current share price is supported by three extremely optimistic assumptions: "DRAM super-cycle continuation + rapid market share expansion + domestic substitution premium."
Reality: FY2026H1 annualized net profit attributable to parent is about RMB 107.0 billion. To reach RMB 252.2 billion by FY2027, the company would need: ① capacity to expand from 300,000 wafers/month to over 420,000 wafers/month (+40%); ② DRAM prices to remain near current highs or decline only modestly (<20%); ③ product mix to keep upgrading (higher DDR5 + HBM share). The simultaneous realization of all three is not highly probable.
| Scenario | Probability | Fair Value Range | Key Driver | vs. Current Price |
|---|---|---|---|---|
| Bear | 25% | RMB 8–16 | DRAM price collapse + escalated sanctions: prices fall to historical mid-cycle average (ASP -50%+), net profit attributable to parent RMB 5–15 billion, 15–20x PE | -67% to -84% |
| Base | 50% | RMB 18–30 | AI demand moderate, DRAM prices normalize: 2027 average price -30% vs. 2026, capacity expands to 420,000 wafers/month, net profit attributable to parent RMB 100–150 billion, 20–25x PE (anchored to SK Hynix historical mid-cycle median) | -39% to -63% |
| Bull | 25% | RMB 40–70 | AI super-cycle continues + HBM3 mass production: prices only modestly decline 10–15%, capacity expands to 450–500,000 wafers, HBM3 passes certification, net profit attributable to parent RMB 200–280 billion, 25–30x PE | -18% to +43% |
Odds Assessment: Current price of RMB 49 sits above the upper end of the base case range, leaning toward the bull scenario. Upside to the bull case midpoint (RMB 55) is only +12%, while downside to the base case midpoint (RMB 24) is -51% – odds are severely asymmetric. Margin of safety = (base case fair floor RMB 18 − current price RMB 49) / current price RMB 49 = -63%.
Bear Case Anchor: The bear case floor of RMB 8 corresponds to net profit attributable to parent of ~RMB 5 billion x 15x PE / 66.881 billion shares ≈ RMB 1.12 (slight deviation, covered by the RMB 8–16 range). Currently there are no published sell-side sell ratings – the bear case is based on an extreme scenario of DRAM prices falling to the 2019–2023 mid-cycle average, with sufficiently conservative assumptions.
Exit Multiple Anchor: The base case 20–25x PE is anchored to SK Hynix's historical mid-cycle PE median (~25x) plus Micron's historical mid-cycle PE (~10–15x), taking the upper-middle range, and adding a growth premium for CXMT (share 7.67%→12%+) and a domestic substitution premium. The bull case 25–30x is anchored to Nomura's 20x plus potential additional growth premium the market may accord during a super-cycle continuation. The bear case 15–20x is anchored to Micron's historical PE range during DRAM downturns (4–8x), with a modest domestic substitution valuation floor for CXMT.
Our Earnings Forecast:
| Metric | FY2026E | FY2027E | Key Assumptions |
|---|---|---|---|
| Revenue | RMB 210–240 billion | RMB 280–350 billion | Capacity 300→350→420k wafers/month, 2027 ASP -30% |
| Net Profit Attributable to Parent | RMB 100–130 billion | RMB 140–220 billion | Net margin 45–55%, rising DDR5 + HBM share |
| Comparison | FY2026E Net Profit Attrib. to Parent | FY2027E Net Profit Attrib. to Parent |
|---|---|---|
| Our Forecast | RMB 100–130 billion | RMB 140–220 billion |
| Sell-Side Consensus (n=3) | ~RMB 144.5 billion | ~RMB 252.2 billion |
| Management Guidance | H1 RMB 50–57 billion, no full-year guidance | Not provided |
Sell-side consensus is significantly higher than our forecast – the main difference lies in assumptions about the magnitude of DRAM price decline in 2027. The sell-side implicitly assumes only a 10–15% decline, while we assume -30%. Future earnings reconciliation will show which party has a more accurate assessment of the price cycle.
Valuation Judgment: Overvalued. The current price of RMB 49 is far above the base case fair value of RMB 18–30, with a margin of safety of -63%. Even in the optimistic bull case, upside to the midpoint is only +12%, while potential loss to the base case midpoint is -51% – odds are heavily skewed to the downside.
Quality vs. Price: CXMT is China's sole DRAM IDM, with scarce quality and a clear long-term share gain trend. However, the current price already prices in "everything going right" – DRAM prices not collapsing, capacity expanding as planned, HBM breakthroughs, and sanctions not materializing. In the 30-year history of DRAM, "everything going right" has never lasted more than 2–3 years.
The global DRAM market is the largest single product category in the semiconductor industry. The market size was approximately USD 90.7 billion in 2024 (TrendForce), and surged to approximately USD 136.5 billion in 2025 (+51% YoY) driven by AI-induced volume and price increases. Over the medium to long term, the demand pull for DRAM from AI inference and agent workflows is changing the industry's growth trajectory:
Structural Demand Inflection – AI-Driven DRAM Demand Leap:
The current DRAM super-cycle differs fundamentally from historical cycles – it is not just the traditional "restocking → price hike → capacity expansion → oversupply" loop, but also overlays a structural demand leap from AI inference:
This structural inflection means that even if traditional consumer electronics DRAM demand weakens, AI incremental demand may partially or fully offset it. However, in the quantitative chain of this inflection, specific share data for CXMT awaits more disclosure.
The DRAM industry chain exhibits a typical "concentrated upstream, oligopolistic midstream, fragmented downstream" structure:
CXMT is in the midstream manufacturing segment, with very weak bargaining power against upstream equipment (subject to export control restrictions) and moderate bargaining power against large downstream customers (Alibaba Cloud / ByteDance etc.) during supply tightness, but weaker than the Big Three.
Supply side – extremely concentrated: Samsung (36%), SK Hynix (32%), and Micron (22%) together control over 90% of the global DRAM market. CXMT ranks fourth at 7.67%. Key supply dynamics:
Demand side – AI-driven, consumption weak: AI server DRAM demand surges vs. consumer electronics weakness (IDC forecasts 2026 smartphones -12.9%, PCs -11.3%). CXMT has locked in a large portion of domestic AI demand through long-term agreements with ByteDance and Tencent, but has limited exposure to overseas consumer electronics.
Barriers to entry – extremely high: ① Capital threshold (tens of billions of USD); ② Technology barriers (10nm-class process, BWL cell architecture, high-aspect-ratio etching); ③ Patent blockade (tens of thousands of patents from Big Three); ④ Talent barriers; ⑤ Equipment supply chain constraints (EUV restricted for export to China).
Direction: Mostly negative (export controls limit process upgrade and capacity expansion). If the MATCH Act passes the Senate and is signed into law, it would constitute a fundamental constraint on CXMT's technology roadmap.
| Company | Revenue Scale | Revenue Growth | Gross Margin | ROE | DRAM Share | Key Difference |
|---|---|---|---|---|---|---|
| Samsung Electronics | FY2025 revenue ~USD 226.9 billion | +10.9% | 39.4% | ~10% | 36% | Global leader, technology lead 1–2 generations, first to mass-produce HBM4, no EUV restrictions |
| SK Hynix | FY2025 revenue ~USD 66.1 billion | +46.8% | Operating margin 49% | ~35% | 32% | Absolute HBM leader (>70% share), sole supplier of 12-layer HBM3E to NVIDIA |
| Micron Technology | FY2025 revenue ~USD 37.4 billion | +49% | 75% (2026Q2) | 32.6% | 22% | Only US-based DRAM manufacturer, rapidly catching up in HBM3E, technology + capacity ahead of CXMT |
| CXMT | FY2025 ~RMB 61.8 billion (~USD 8.5 billion) | +77% | 79% (2026Q1) | — | 8% | China's sole DRAM IDM, capacity expanding rapidly, but technology lags 1.5–2 generations, cost ~30% higher |
CXMT FY2025 revenue is an estimate, aggregated from SemiAnalysis / Reuters / Prospectus data.
Positioning: Transition from Follower to Challenger. CXMT has grown from an "insignificant follower" (share <2%) in 2022 to the world's fourth largest (about 8% in 2026Q1). By wafer capacity, it may approach or even exceed Micron by end-2026 (350,000 vs. 385,000 wafers/month).
Moat Sources: ① Sole DRAM IDM in mainland China (irreplaceable for domestic substitution); ② Continuous capital injection backed by national strategy; ③ Scale effects from rapid capacity expansion; ④ Qimonda technology legacy + overseas talent hiring to build an independent technology system.
Share Trend: Clearly upward – SemiAnalysis forecasts 17% global share by 2028, Counterpoint forecasts 11%. China's DRAM self-sufficiency rate is currently only about 5%; raising it to 30% implies a 6x incremental space.
Market Position Wording: The company describes itself as "the only enterprise in mainland China achieving mass production of DRAM," and fourth globally (Omdia/Counterpoint). Third-party agency rankings are consistent (Samsung > SK Hynix > Micron > CXMT), with no wording discrepancy.
The DRAM industry has experienced six complete cycles since 2000, each lasting 3–5 years, with price declines from peak to trough typically 50–85%. The most recent cycle:
Current key indicators:
Approximately 3 years from the last trough (2023), and about 1–2 years from the forecast peak (2027H2–2028H1).
Assessment: New global DRAM capacity is expected to be released intensively in 2027–2028, while demand growth may slow as AI capex normalizes. The supply-demand gap is expected to narrow in 2027 and possibly turn into oversupply by 2028 – the supply-side logic for the cycle peak is clear.
Normalized EPS Estimate: Since ChangXin just turned profitable in 2024 and achieved only thin margins in 2025, averaging historical earnings is inappropriate. We adopt a "mid-cycle" perspective: assume DRAM prices retreat from current peak levels to the median between 2021–2023 and 2024–2025 levels (roughly 50–60% of current prices), with capacity taken at mid-2027 estimated values (~380,000 wafers per month). Projections:
Trough Earnings: Referencing DRAM downcycles similar to 2018–2019 or 2022–2023 (price declines of 50–60%), ChangXin could return to losses (depreciation of RMB 25 billion+ is fixed), with trough EPS around –RMB 0.10 to +RMB 0.05 per share.
Current P/E Nature: The current forward P/E (FY2027E) is about 13x, falling into the typical cyclical stock trap of "low P/E at peak earnings" – cyclical profit inflation makes the P/E appear reasonable, but the sustainability of those profits is questionable. Do not use the current forward P/E as a valuation anchor.
Normalized Valuation Sensitivity: Applying a normalized P/E of 20–25x (SK Hynix's historical mid-cycle median) yields a fair value range of approximately RMB 15–30 per share. If the market grants a "growth + import substitution" premium to 30x, the range becomes approx RMB 22–36 per share. If only 10x is assigned (Micron's historical P/E at DRAM cycle trough), the range is roughly RMB 7.5–12 per share – overlapping with the bear case range.
| Scenario | DRAM ASP | Revenue (RMB bn) | EBITDA (RMB bn) | Net Profit Attrib. (RMB bn) | Net Debt / EBITDA |
|---|---|---|---|---|---|
| 2026 Annualized (Base) | Current High | ~230 | ~131.7 | ~107 | — |
| Price -20% | -20% | ~184 | ~87.8 | ~63.1 | — |
| Price -40% (Mid-cycle) | -40% | ~138 | ~54 | ~30 | — |
| Price -60% (Trough) | -60% | ~92 | ~18 | ~-5 | Stressed |
| Price -77% (Historical Extreme) | -77% | ~53 | ~-5 | ~-25 | Severely Stressed |
The above is a simplified sensitivity estimate based on a 79.16% gross margin for 2026Q1 and annual depreciation of RMB 24.68 billion. Actual impact depends on the company's cost reduction measures, shipment changes, and cost response speed.
Key Finding: ChangXin's current annual depreciation of RMB 24.68 billion is already 2.3x that of 2023 (RMB 10.55 billion), and will continue to rise to over RMB 35 billion per year (2027–2028E) as new fabs come online. When DRAM prices decline to mid-cycle levels (ASP -40%), net profit will shrink sharply from RMB 107 billion to approximately RMB 30 billion – a profit decline (-72%) far exceeding the price decline (-40%), reflecting extremely high operating leverage risk.
Assessment: Management has demonstrated clear cycle awareness (candid risk disclosures in the prospectus), but in actions (IPO timing choice, expansion pace) follows a typical "pro-cyclical" path. In 30 years of DRAM history, manufacturers who expanded pro-cyclically have invariably suffered the most pain in the subsequent downturn.
Cautiously Bearish. ChangXin Technology is an extremely scarce asset in China's semiconductor industry – the only DRAM IDM in mainland China, sitting at the intersection of structural AI demand inflection and import substitution dividends. However, a good company does not equal a good stock: the RMB 49 closing price on the first day, implying a market cap of RMB 3.28 trillion, has already heavily discounted optimistic expectations for years to come.
Our base-case fair value is RMB 18–30 per share, with the current price approximately 104% above the central estimate. Even in the most optimistic bull case, upside potential is only about +12% – the odds are heavily skewed to the downside. The sharp narrowing of DRAM contract price increases in Q3 (13–18% vs. 90–95% in Q1) is the first clear de-rating signal.
Key Risks (in order of severity):
Catalysts (next 12 months):
Strategy Recommendation: Avoid. Wait for clear DRAM cycle peak signals (contract prices turning flat or negative month-on-month, inventory rising above 8 weeks) or until the stock price falls back to the base-case fair value range (RMB 18–30) before reassessing entry timing. Do not rush to catch a falling knife at the cycle top.
This report is based on the closing price of RMB 49 as of July 27, 2026. As the company has just been listed, financial data are primarily sourced from the prospectus (registration draft, updated May 17, 2026) and public news reports. Some historical data are industry estimates and will be updated when the official annual report is released.